BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21394831)

  • 1. Combined characterization of microRNA and mRNA profiles delineates early differentiation pathways of CD133+ and CD34+ hematopoietic stem and progenitor cells.
    Bissels U; Wild S; Tomiuk S; Hafner M; Scheel H; Mihailovic A; Choi YH; Tuschl T; Bosio A
    Stem Cells; 2011 May; 29(5):847-57. PubMed ID: 21394831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Megakaryocytic differentiation of CD133+ hematopoietic stem cells by down-regulation of microRNA-10a.
    Zarif MN; Soleimani M; Abolghasemi H; Amirizade N; Arefian E; Rahimian A
    Hematology; 2013 Mar; 18(2):93-100. PubMed ID: 23321646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of miRNA and mRNA expression in childhood medulloblastoma compared with neural stem cells.
    Genovesi LA; Carter KW; Gottardo NG; Giles KM; Dallas PB
    PLoS One; 2011; 6(9):e23935. PubMed ID: 21931624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells.
    Pomyje J; Zivný J; Sefc L; Plasilová M; Pytlík R; Necas E
    Eur J Haematol; 2003 Mar; 70(3):143-50. PubMed ID: 12605658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA profiling of a CD133(+) spheroid-forming subpopulation of the OVCAR3 human ovarian cancer cell line.
    Nam EJ; Lee M; Yim GW; Kim JH; Kim S; Kim SW; Kim YT
    BMC Med Genomics; 2012 May; 5():18. PubMed ID: 22643117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biology and plasticity of CD133+ hematopoietic stem cells.
    Handgretinger R; Gordon PR; Leimig T; Chen X; Buhring HJ; Niethammer D; Kuci S
    Ann N Y Acad Sci; 2003 May; 996():141-51. PubMed ID: 12799292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding proteins-2 and -4 enhance the migration of human CD34-/CD133+ hematopoietic stem and progenitor cells.
    Bartling B; Koch A; Simm A; Scheubel R; Silber RE; Santos AN
    Int J Mol Med; 2010 Jan; 25(1):89-96. PubMed ID: 19956906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
    Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
    Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CDCP1 identifies a broad spectrum of normal and malignant stem/progenitor cell subsets of hematopoietic and nonhematopoietic origin.
    Bühring HJ; Kuçi S; Conze T; Rathke G; Bartolović K; Grünebach F; Scherl-Mostageer M; Brümmendorf TH; Schweifer N; Lammers R
    Stem Cells; 2004; 22(3):334-43. PubMed ID: 15153610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells.
    Takahashi M; Matsuoka Y; Sumide K; Nakatsuka R; Fujioka T; Kohno H; Sasaki Y; Matsui K; Asano H; Kaneko K; Sonoda Y
    Leukemia; 2014 Jun; 28(6):1308-15. PubMed ID: 24189293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene and miRNA expression profiles of hematopoietic progenitor cells vary depending on their origin.
    Báez A; Martín-Antonio B; Piruat JI; Barbado MV; Prats C; Álvarez-Laderas I; Carmona M; Pérez-Simón JA; Urbano-Ispizua Á
    Biol Blood Marrow Transplant; 2014 May; 20(5):630-9. PubMed ID: 24462744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
    Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
    Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased number of circulating progenitor cells after implantation of ventricular assist devices.
    Manginas A; Tsiavou A; Sfyrakis P; Giamouzis G; Tsourelis L; Leontiadis E; Degiannis D; Cokkinos DV; Alivizatos PA
    J Heart Lung Transplant; 2009 Jul; 28(7):710-7. PubMed ID: 19560700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control.
    Georgantas RW; Hildreth R; Morisot S; Alder J; Liu CG; Heimfeld S; Calin GA; Croce CM; Civin CI
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2750-5. PubMed ID: 17293455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-146a and miR-150 promote the differentiation of CD133+ cells into T-lymphoid lineage.
    Fallah P; Arefian E; Naderi M; Aghaee-Bakhtiari SH; Atashi A; Ahmadi K; Shafiee A; Soleimani M
    Mol Biol Rep; 2013 Aug; 40(8):4713-9. PubMed ID: 23673476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3.
    Guo R; Wu Q; Liu F; Wang Y
    Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel subpopulation of human cord blood CD34-CD133-CD7-CD45+lineage- cells capable of lymphoid/NK cell differentiation after in vitro exposure to IL-15.
    Rutella S; Bonanno G; Marone M; De Ritis D; Mariotti A; Voso MT; Scambia G; Mancuso S; Leone G; Pierelli L
    J Immunol; 2003 Sep; 171(6):2977-88. PubMed ID: 12960322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133+ cell content does not influence recovery time after hematopoietic stem cell transplantation.
    Jaime-Pérez JC; Guillermo-Villanueva VA; Méndez-Ramírez N; Chapa-Rodríguez A; Gutiérrez-Aguirre H; Gómez-Almaguer D
    Transfusion; 2009 Nov; 49(11):2390-4. PubMed ID: 19903294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.